Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
CBN and CBD · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| CBN and CBD | DIETARY_SUPPLEMENT | CBN and CBD in Gummy Format |
CBN and CBD is an investigational combination of two cannabinoids being studied for its effects on sleep quality in healthy adults. It is currently in Phase 2 clinical development and is not approved by the FDA. The product is being developed by Canopy Growth Corporation.
CBN and CBD is being developed by Canopy Growth Corporation, a company listed on the stock exchange under the ticker CGC. The company is conducting clinical research on this cannabinoid combination for sleep quality in healthy adults.
CBN and CBD is in Phase 2 clinical development. It is an investigational product and has not been approved by regulatory authorities. One clinical trial has been completed, and no trials are currently active.
CBN and CBD has one completed clinical trial registered under NCT05839964, titled 'A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality.' The trial enrolled 301 healthy adults and was a Phase 1/Phase 2 study.
CBN and CBD is a combination product containing both cannabinol (CBN) and cannabidiol (CBD). It is distinct from CBD alone, as it includes both cannabinoids. The clinical trial studied the effects of CBN with and without CBD on sleep quality.